The Punjab health authorities have issued a recall of four medicine batches after the provincial Drug Testing Laboratories declared them substandard and adulterated.

The products include DryGlit syrup, Trezine tablets, Zinad tablets and Bemin tablets.

The notice says DryGlit 120mL syrup was found to be substandard because its ethylene glycol content exceeded permissible limits. The affected batches are S13326 and S13426, with an expiry date of June 2028.

The remaining three products were classified as adulterated: Trezine (Cetirizine 10mg) batch No. 307, expiring April 2027. Zinad (Tizanidine 2mg) batch 5F001, expiring June 2028, and Bemin (Mecobalamin 500mcg) batch 093, expiring September 2027.

Punjab authorities have instructed pharmacies, wholesalers, distributors and healthcare facilities to immediately stop dispensing the affected batches.

They have also been asked to report their existing stocks and consumption records to the relevant drug inspectors.

The notice directs the manufacturers and market authorization holders to initiate recalls and submit details including a recall assessment, root-cause analysis and corrective and preventive action plans.

The provincial authorities have also called for enhanced surveillance across the medicine supply chain to ensure traceability of the affected products.

The government has advised consumers and patients to stop using the listed batches immediately, warning that they may pose a risk to health.